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We are delighted to announce the launch of this first issue
of Clinical Epigenetics, a new peer-reviewed journal, which
publishes original (not previously published) work of
exceptional quality and interest and which intends to give
a wide-ranging coverage of research, views, and reviews on
epigenetic principles and mechanisms, and their effects in
relation to human health and disease. Clinical Epigenetics
will include epigenetic research in humans and various
disease model organisms and will be of interest to the basic
researcher as well as to the physician scientist and the
clinician.
The Journal is published by Springer, will start on a
quarterly publication schedule, and will provide a forum to
a readership that is interested in practical questions in
clinical epigenetics, and the implications of epigenetics on
human health and disease. It will serve as the official
publication for the Clinical Epigenetics Society, for a non-
profit international association of physicians, scientists, and
interested individuals with the goal of promoting and
supporting scientific research and communication within
the field of clinical epigenetics.
Clinical Epigenetics is the first journal dedicated to the
connection of epigenetic patterns to human physiology and
disease.The Journal willbepublished bothinprint andonline
with an option for open access. All articles will be promptly
peer-reviewed by leading experts. We expect Clinical
Epigenetics to attract manuscripts of the highest quality in
order to be of the greatest possible benefit to its readers.
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